In the Spring of 2008 Zen Chu (Accelerated Medical Ventures) gave what became a groundbreaking presentation and discussion on Venture Capital in Medicine.
Last week, we revisited the subject of VC in Healthcare with Zen, but this time with the aim of talking about the new age. Clearly, the playbook has changed in recent months since the economic slowdown, and to tackle the topic Zen brought along Michael Greeley (Flybridge Capital Partners), Elazer Edelman, MD, PhD (Harvard Medical School/Highland Capital), Joe Smith, MD, PhD (VP, Emerging Technologies, Johnson & Johnson) and Marsha Moses, PhD (Children's Hospital Boston, Harvard Medical School).
What Zen and his crew have brought us is another fundamentally important set of talks that hit home for everyone involved with healthcare.
Zen introduces the healthcare innovation landscape, funding sources for R&D and commercialization, major value drivers and funding milestones. He also describes teams needed for medical ventures and roles for physicians from invention through clinical trials - running time: 7 minutes
Here are the New Playbook for Healthcare Innovation presentation slides, including some not shown in the video. Zen Chu's popular presentation High Impact Clinical Innovation: Strategies and Techniques are also linked below.
Next, we launch into the panel discussion where Michael Greeley wants to know about the realities of today’s economic situation - running time: 7 minutes
The panel then explores the capital gap, a lack of liquidity in the markets, and how to navigate to continue developing companies – running time: 10 minutes
Then the panel covers the checklist for investment, how parameters for investment have changed, and how to clear early hurdles – running time: 13 minutes
Finally, we take questions form the audience, which cover: setting the bar in medicine, global influence/innovation, realities of bootstrapping, early stage seed money, SBIR’s, and physician adoption/culture – running time: 20 minutes
Speakers: ZEN CHU (Accelerated Medical Ventures) . ELAZER EDELMAN, MD, PhD (MIT / HST / Harvard Medical School / Highland Capital) . MICHAEL GREELEY (Flybridge Capital Partners) . MARSHA MOSES, PhD (Children's Hospital Boston, Harvard Medical School) . JOE SMITH, MD, PhD (VP, Emerging Technologies, Johnson & Johnson COSAT)